People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology, Software / Tech, Manufacturing / Industrial
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Remedy Plan, Inc. | — | Biotechnology | Series B | $25.8M | $202.4M | 2019 |
| JETCOOL Technologies Inc. | — | Software / Tech | Series B | $21.1M | $230.4M | 2021 |
| Amplified Industries, Inc. | — | Manufacturing / Industrial | Series A | $13.4M | $38.4M | 2025 |
Alexandra Manick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alexandra Manick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Andonian | 1 | 8 |
| Frank McCormick | 1 | 7 |
| Adam Jackson | 1 | 7 |
| Owen Hughes | 1 | 4 |
| Lawrence Fish | 1 | 2 |
| Bernard Malouin Jr. | 1 | 1 |
| Bernard Malouin | 1 | 1 |
| Gregory Crimmins | 1 | 1 |
| Gregory Plan Crimmins | 1 | 1 |
| Sebastien Mannai | 1 | 1 |
| William Severns | 1 | 1 |
| Louis Creteur | 1 | 1 |
| Charles-Henri Clerget | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.